Stay up to date with the latest advancements, clinical insights, and platform updates from the BioPortal research team.
BioPortal is officially accepting data access applications from researchers globally, offering deep-phenotyped, multi-modal data for thousands of diabetes patients.
Watch Dr. Brent Richards discuss how large-scale genomics and proteomics are improving common disease care, featuring an overview of the JGH BioPortal program.
A new $9.4M+ collaborative research initiative aims to identify biomarkers and therapeutic solutions for diabetic kidney disease using genomic, proteomic, and clinical data.